Despite the stock’s volatility, the company reaffirmed its optimism on its AI infrastructure business by projecting $3.4 ...

Nektar Therapeutics stock is trading lower Monday afternoon as the market continues to assess mixed topline results from the ...

Relief rally underway in Novo Nordisk after a difficult year for the stock which saw it lose ground to arch-competitor Eli ...

On Dec. 23, 2025, investors weighed a newly approved oral obesity pill’s first-mover edge and its ripple effects across healthcare.

Event‑driven traders are zeroing in on merger‑arbitrage spreads and deal risk around this $8.4 billion buyout, today, Dec. 22, 2025.

This article has been updated to reflect that Eli Lilly & Co. would become the 10th company to attain a $1 trillion market capitalization in the U.S. Eli Lilly & Co.’s stock is once again in ...

The U.S. earnings season has kicked off for the third quarter. Earnings give us extra insight into how the economy is going, but more importantly, data shows earnings are important to stock prices.

US stocks slid on Monday, while bitcoin's (BTC-USD) slump deepened as Wall Street's strong late-November rebound took a rockier turn to begin December. Some of Wall Street's biggest names bucked the ...

The cryptocurrency slump is deepening to start the month. Bitcoin fell 6.4%, its largest daily decrease since March 3, according to Dow Jones Market Data. The decline hurt shares of crypto-focused ...

The federal government has announced the results of the latest round of Medicare drug price negotiations: 15 lower drug prices for Medicare to go into effect in 2027. Medicare will get a 71% discount ...

Farran Powell is the managing editor of investing at Forbes Advisor. She was previously the assistant managing editor of investing at U.S. News & World Report. Her work has appeared in numerous ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.